CARBOXYMALTOSE FERRIQUE TEVA 50 mg/ml, injectable dispersion/for infusion bottle, 2 ml
Active ingredients: Ferric carboxymaltose, Iron
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for injection or infusionbottle, 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARBOXYMALTOSE FERRIQUE TEVA 50 mg/mL, dispersion injectable/pour perfusion
- Pharmaceutical form
- dispersion injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 2 mL contenant 100 mg de fer
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Aug 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61426630CIP75510259CIP133400955102595Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FERdispersion | 50 mg · 1 mL de dispersion | FT |
| CARBOXYMALTOSE FERRIQUEdispersion | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.